Pharmafile Logo

Beacon consulting

Beacon Consulting is a specialist pharmaceutical consultancy. We help our clients solve difficult commercial problems and maximise the opportunities for their brands by providing actionable, data driven analysis. We focus on using NHS secondary data sources such as Hospital Episode Statistics (HES), QoF and GP prescribing data to add insight to challenges in: estimating market sizes, modelling patient flows through the health care system, describing variation in treatment practice, patient and physician segmentation, profiling and targeting, forecasting and examining healthcare resource usage and costs.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Foxacre, Parkland Grove, Farnham, Surrey, GU9 9HA, United Kingdom
+44 (0)1252 758988

 Latest Content from PMHub 

Biosimilars: Bringing patients into the conversation

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

White Papers and Resources | January 25, 2017 | Inizio

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

White Papers and Resources | January 25, 2017 | Inizio

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

White Papers and Resources | January 25, 2017 | Inizio

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...

Nutraceuticals in India: A Challenging Opportunity

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma December 2016 by Marc Yates

Research Partnership makes annual donation to Forever Projects

White Papers and Resources | January 25, 2017 | Inizio

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...

Introduction to the manufacturing of biologics

The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the...